Medical Considerations Low IGF-1 with symptoms of GH deficiency may warrant: GH stimulation testing Consideration of GH or peptide therapy under endocrinology or functional medicine guidance High IGF-1 may require: Acromegaly screening (IGF-1 + oral glucose tolerance GH suppression test) Adjustment of therapy dosages Cancer risk assessment and monitoring IGF-1, Longevity, and Health Span The relationship between IGF-1 and lifespan is U-shaped both extremes are associated with higher risk
Licensed weight-management medicines currently available in the UK include: Semaglutide (Wegovy) approved by the MHRA for chronic weight management in adults with a BMI of 30 kg/m or above, or 27 kg/m or above with at least one weight-related comorbidity
During treatment, periodic follow-up matters more than many people expect
Using Seahorse extracellular flux analysis, we measured oxygen consumption rates (OCRs) in activated naive (CD44 low ) CD8 + T cells cultured under low-nutrient, fatty acid oxidation (FAO)-permissive conditions
Eating too little can backfire by slowing your metabolism and causing muscle loss
Practical guidelines for the management of toxic epidermal necrolysis and StevensJohnson syndrome